Ticker Details
Penumbra, Inc. Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures.
IPO Date:	September 18, 2015
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$13.31B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$3.06 | 1.76%
Avg Daily Range (30 D):	$2.48 | 0.75%
Avg Daily Range (90 D):	$3.30 | 1.14%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	1.27M
Avg Daily Volume (90 D):	.67M

Trade Size
Avg Trade Size (Sh.):	48
Avg Trade Size (Sh.) (30 D):	36
Avg Trade Size (Sh.) (90 D):	32

Institutional Trades
Total Institutional Trades:	3,977
Avg Institutional Trade:	$6.48M
Avg Institutional Trade (30 D):	$17.63M
Avg Institutional Trade (90 D):	$14.97M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$8.45M
Avg Closing Trade (30 D):	$41.99M
Avg Closing Trade (90 D):	$26.37M
Avg Closing Volume:	40.06K

News

Feb 2, 2026 @ 10:49 PM Halper Sadeh LLC Reminds Shareholders of RAPT, PEN... Source: Halper Sadeh Llc

Jan 28, 2026 @ 7:23 PM $HAREHOLDER ALERT: The M&A Class Action Firm Is In... Source: Prnewswire

Jan 21, 2026 @ 9:52 PM Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC ... Source: Halper Sadeh Llc

Jan 21, 2026 @ 5:30 PM Boston Scientific Advises Removal Of Certain AXIOS... Source: Vandana Singh

Jan 17, 2026 @ 5:45 PM Halper Sadeh LLC Encourages PEN, CVGW, AVO Shareho... Source: Halper Sadeh Llc

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$4.23	$1.17	$1.17
Diluted EPS	$4.19	$1.17	$1.15
Revenue	$1.33B	$354.69M	$339.46M
Gross Profit	$891.03M	$240.42M	$224.01M
Net Income / Loss	$164.03M	$45.85M	$45.27M
Operating Income / Loss	$172.79M	$48.84M	$40.83M
Cost of Revenue	$442.77M	$114.27M	$115.45M
Net Cash Flow	$40.55M	$-100.74M	$45.71M
PE Ratio	81.05